SEC23B and neoplasm: To obtain insights into the impact of SEC23B mutations clinically, we further examined the significance of SEC23B on CRC progression, and found that patients with lower level of SEC23B tended to have shorter survival (Fig. 8c), indicating that low level of SEC23B accelerate tumor progression.